Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury.
The use of typical neuroleptics has always been the mainstay of treatment for delirium following traumatic brain injury (TBI). Given the recent application of atypical neuroleptics to various psychiatric conditions formerly treated with typical neuroleptics, one questions whether this new class of drugs is superior to its predecessor in treating delirium post-TBI. We present a case of one patient with TBI-induced delirium where in fact the use of the typical mid-potency neuroleptic, loxapine, appeared to have a better clinical effect over the atypical neuroleptic, olanzapine.
Krieger
Deborah
D
University of Alberta Medical School, Edmonton, Alberta, Canada.
Hansen
Keith
K
McDermott
Colleen
C
Matthews
Roy
R
Mitchell
Rachel
R
Bollegala
Natasha
N
Bhalerao
Shree
S
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D001930:Brain Injuries / Q000150:complications*; D003693:Delirium / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008152:Loxapine / Q000627:therapeutic use*; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D008152:Loxapine; D000077152:Olanzapine